You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Takaaki Matsuura1,2, Daisuke Kawahara2, Akito Saito3
1Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
This study introduces a novel artificial intelligence system using a generative adversarial network (GAN) to predict failing points in volumetric modulated arc therapy (VMAT) quality assurance (QA). The AI system accurately identifies dose discrepancies, enhancing patient-specific radiotherapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: